Shenzhen Salubris Pharmaceuticals Statistics

Total Valuation

Shenzhen Salubris Pharmaceuticals has a market cap or net worth of CNY 34.48 billion. The enterprise value is 32.69 billion.

Market Cap	34.48B
Enterprise Value	32.69B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Jun 19, 2024

Share Statistics

Shenzhen Salubris Pharmaceuticals has 1.11 billion shares outstanding. The number of shares has increased by 0.23% in one year.

Current Share Class	n/a
Shares Outstanding	1.11B
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	-0.28%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	15.05%
Float	435.90M

Valuation Ratios

The trailing PE ratio is 56.27 and the forward PE ratio is 51.55.

PE Ratio	56.27
Forward PE	51.55
PS Ratio	8.79
PB Ratio	4.01
P/TBV Ratio	n/a
P/FCF Ratio	61.44
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 34.20, with an EV/FCF ratio of 58.24.

EV / Earnings	53.53
EV / Sales	8.36
EV / EBITDA	34.20
EV / EBIT	55.03
EV / FCF	58.24

Financial Position

The company has a current ratio of 3.72, with a Debt / Equity ratio of 0.01.

Current Ratio	3.72
Quick Ratio	2.51
Debt / Equity	0.01
Debt / EBITDA	0.08
Debt / FCF	0.14
Interest Coverage	37.83

Financial Efficiency

Return on equity (ROE) is 7.42% and return on invested capital (ROIC) is 4.39%.

Return on Equity (ROE)	7.42%
Return on Assets (ROA)	3.78%
Return on Capital (ROIC)	4.39%
Revenue Per Employee	1.11M
Profits Per Employee	173,615
Employee Count	3,517
Asset Turnover	0.40
Inventory Turnover	2.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.46% in the last 52 weeks. The beta is 0.67, so Shenzhen Salubris Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-2.46%
50-Day Moving Average	32.80
200-Day Moving Average	29.55
Relative Strength Index (RSI)	35.60
Average Volume (20 Days)	8,337,824

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shenzhen Salubris Pharmaceuticals had revenue of CNY 3.91 billion and earned 610.61 million in profits. Earnings per share was 0.55.

Revenue	3.91B
Gross Profit	2.79B
Operating Income	593.96M
Pretax Income	666.09M
Net Income	610.61M
EBITDA	937.49M
EBIT	593.96M
Earnings Per Share (EPS)	0.55

Full Income Statement

Balance Sheet

The company has 1.91 billion in cash and 78.40 million in debt, giving a net cash position of 1.83 billion or 1.64 per share.

Cash & Cash Equivalents	1.91B
Total Debt	78.40M
Net Cash	1.83B
Net Cash Per Share	1.64
Equity (Book Value)	8.64B
Book Value Per Share	7.72
Working Capital	2.75B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.16 billion and capital expenditures -597.18 million, giving a free cash flow of 561.22 million.

Operating Cash Flow	1.16B
Capital Expenditures	-597.18M
Free Cash Flow	561.22M
FCF Per Share	0.50

Full Cash Flow Statement

Margins

Gross margin is 71.37%, with operating and profit margins of 15.19% and 15.62%.

Gross Margin	71.37%
Operating Margin	15.19%
Pretax Margin	17.04%
Profit Margin	15.62%
EBITDA Margin	23.98%
EBIT Margin	15.19%
FCF Margin	14.35%

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 1.60%.

Dividend Per Share	0.50
Dividend Yield	1.60%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	89.43%
Buyback Yield	-0.23%
Shareholder Yield	1.37%
Earnings Yield	1.78%
FCF Yield	1.63%

Dividend Details

Stock Splits

The last stock split was on April 24, 2015. It was a forward split with a ratio of 1.6.

Last Split Date	Apr 24, 2015
Split Type	Forward
Split Ratio	1.6

Scores

Shenzhen Salubris Pharmaceuticals has an Altman Z-Score of 13.89.

Altman Z-Score	13.89
Piotroski F-Score	n/a